Bio-Rad Laboratories, Inc. (BIO) Misses Q1 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $384.40 -0.19%
EPS Growth %: -1.3%
Financial Fact:
Interest expense: 5.63M
Today's EPS Names:
RBKB, ASBH, CMSG, More
EPS Growth %: -1.3%
Financial Fact:
Interest expense: 5.63M
Today's EPS Names:
RBKB, ASBH, CMSG, More
Join SI Premium – FREE
Bio-Rad Laboratories, Inc. (NYSE: BIO) reported Q1 EPS of $1.16, $0.16 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $485.1 million versus the consensus estimate of $482.11 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference
- American Savings Bank, National Association (ASBH) Tops Q3 EPS by 46c
- AptarGroup (ATR) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
